Literature DB >> 8801433

Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

T F Murphy1.   

Abstract

Over the past decade, Branhamella catarrhalis has emerged as an important human pathogen. The bacterium is a common cause of otitis media in children and of lower respiratory tract infections in adults with chronic obstructive pulmonary disease. B. catarrhalis is exclusively a human pathogen. It colonizes the respiratory tract of a small proportion of adults and a larger proportion of children. Studies involving restriction enzyme analysis of genomic DNA show that colonization is a dynamic process, with the human host eliminating and acquiring new strains frequently. The surface of B. catarrhalis contains outer membrane proteins, lipooligosaccharide, and pili. The genes which encode several outer membrane proteins have been cloned, and some of these proteins are being studied as potential vaccine antigens. Analysis of the immune response has been limited by the lack of an adequate animal model of B. catarrhalis infection. New information regarding outer membrane structure should guide studies of the human immune response to B. catarrhalis. Immunoassays which specifically detect antibodies to determinants exposed on the bacterial surface will elucidate the most relevant immune response. The recognition of B. catarrhalis as an important human pathogen has stimulated research on the epidemiology and surface structures of the bacterium. Future studies to understand the mechanisms of infection and to elucidate the human immune response to infection hold promise of developing new methods to treat and prevent infections caused by B. catarrhalis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801433      PMCID: PMC239443          DOI: 10.1128/mr.60.2.267-279.1996

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  174 in total

1.  Quantitative analysis of the bacterial findings in otitis media.

Authors:  L E Stenfors; S Räisänen
Journal:  J Laryngol Otol       Date:  1990-10       Impact factor: 1.469

2.  Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection.

Authors:  A Verghese; E Berro; J Berro; B W Franzus
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

3.  Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media.

Authors:  H Faden; Y Harabuchi; J J Hong
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

4.  Cefixime compared with amoxicillin for treatment of acute otitis media.

Authors:  C E Johnson; S A Carlin; D M Super; J M Rehmus; D G Roberts; N C Christopher; J K Whitwell; P A Shurin
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

5.  Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children.

Authors:  M M Aspin; A Hoberman; J McCarty; S E McLinn; S Aronoff; D J Lang; A Arrieta
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

6.  Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads.

Authors:  H Faden; J J Hong; N Pahade
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-07       Impact factor: 1.547

7.  Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.

Authors:  V N Gan; H Kusmiesz; S Shelton; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

8.  Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis.

Authors:  L A Burman; M Leinonen; B Trollfors
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

9.  Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238).

Authors:  P Edebrink; P E Jansson; M M Rahman; G Widmalm; T Holme; M Rahman; A Weintraub
Journal:  Carbohydr Res       Date:  1994-05-05       Impact factor: 2.104

10.  The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens.

Authors:  R H Yu; A B Schryvers
Journal:  Microb Pathog       Date:  1993-12       Impact factor: 3.738

View more
  70 in total

1.  Serum intercellular adhesion molecule 1 variations in young children with acute otitis media.

Authors:  Keyi Liu; Janet Casey; Michael Pichichero
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

3.  A cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogens.

Authors:  R J Davidson; D E Low
Journal:  Can J Infect Dis       Date:  1999-03

4.  Characterization of a novel porin protein from Moraxella catarrhalis and identification of an immunodominant surface loop.

Authors:  Donna M Easton; Adam Smith; Sara Gomez Gallego; A Ruth Foxwell; Allan W Cripps; Jennelle M Kyd
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

5.  Moraxella, down but not out--the eye bug that won't go away.

Authors:  J P Whitcher; V Cevallos
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

6.  A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes.

Authors:  Wei Wang; Melanie M Pearson; Ahmed S Attia; Robert J Blick; Eric J Hansen
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

7.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

8.  Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope.

Authors:  J C McMichael; M J Fiske; R A Fredenburg; D N Chakravarti; K R VanDerMeid; V Barniak; J Caplan; E Bortell; S Baker; R Arumugham; D Chen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.

Authors:  L E Myers; Y P Yang; R P Du; Q Wang; R E Harkness; A B Schryvers; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 10.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.